NFKB1 and psoriasis: Similarly, a selenium-enriched yeast peptide fraction (SeP) has demonstrated anti-inflammatory effects in psoriasis treatment by inhibiting both the MAPK and NF-κB pathways, although the specific molecular targets of these peptides have yet to be fully elucidated [91].